|SHOULD I START CLINICAL TRIAL? DESPERATE FOR ANSWER.
May 3, 2009
just newly diagnosed about a month ago. i think i had a false positive hiv result when i got tested last year. cd4 count a month ago was 184. rechecked 2 weeks later and dropped to 118. my doc is recommending a clinical trial from gilead (4 in 1 pill once a day vs atripla). i was more confident in joining when my count was 184, but at 118, i just dont know.
do the benefits still outweight the risks to join this trial? what is usually the recommended drug combo choice for my tcell count? i was thinking truvada and isentress? also, would my t cell count drop another 60 in the next two weeks since i am waiting on my genotype testing already on bactrim and no symptoms as of yet (thank you, god).
thanks for responding!!! i really need to know
| Response from Dr. Holodniy
The Gilead "quad pill" is essentially the same thing as truvada and isentress, except it is their new integrase inhibitor + booster drug. So that regimen is likely to very effective for you. Remember, as with any clinical trial, you have the right to withdraw at any time.
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Will A Person That Has Chlamydia Always Have The Disease?
- When You Have Genital Herpes How Often Will I Break Out?
- What Do Genital Warts Look Like In The Vagina?
- What Do Genital Herpes Look Like When They First Start?
- What Are My Chances Of Catching Chlamydia?
- Is Uti Medication The Same As Gonorrhea?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.